demant_purpose_thomas_hirup_frankly_p9530226_1920x550

Life-changing
hearing health

Through more than 115 years, our company has developed hearing health and from this platform, we have taken new steps into the broader area of audio.

Tune in to life portrays life inside Demant and how our products and services enable users to tune in to the things that matter. In a cinematic journey into our world of hearing health,  we invite viewers into our sound studios, our labs, our hearing care clinics and into the heart of our production and distribution – and we see how teamwork across borders and departments forms an indispensable foundation for our daily work.

[iframe data-category-consent="cookie_cat_marketing" data-consent-src="//wdh.23video.com/15509025.ihtml/player.html?token=f9cbf980da64af4b4c9dff993a615ecd&source=embed&photo%5fid=81557005" width="900" height="655" frameborder="0" border="0" scrolling="no" mozallowfullscreen="1" webkitallowfullscreen="1" allowfullscreen="1" allow="autoplay; fullscreen"][/iframe]
tune-in-to-life-reception
  • demant-frontpage-interim-report-2022_11

    Interim Management Statement 2022

    In Q3, the Demant Group generated revenue growth of 11% (1% organic). Despite solid performance in Diagnostics and slightly positive exchange rate effects, the Group's EBIT was below expectations. Outlook for 2022 has been adjusted to reflect lower-than-expected performance in Hearing Care, Hearing Aids and Communications and continued weak market developments. Read the company announcement and find a link to the recorded webcast and the presentation here.


     
  • acquisition-of-shengwang

    Demant completes full acquisition of ShengWang

    On Tuesday 14 June 2022, Demant announced the acquisition of the remaining 80% of the shares in ShengWang, thereby taking full ownership of the leading network of hearing aid clinics in China. The investment represents a significant strategic transaction in Demant’s continuous journey within hearing healthcare. Read the company announcement here. 
  • oticon-medical-logo

    Demant intends to divest its Hearing Implants business

    Demant has negotiated an agreement with the intention to divest its Hearing Implants business, Oticon Medical, to Cochlear. The contemplated transaction follows a review of strategic options for the business area, including how to ensure the best lifelong support of existing patients - read the announcement. You will find a link to the recorded webcast and the presentation here.  
our-business-world-map

Total number of employees: around 20,000
Revenue in 2021: 18,418 MDKK
Operating profit in 2021: DKK 3,386 million
Presence: 130 countries
Employee gender distribution: 62% women and 38% men
CO2 emission reductions by 2030: minimum 50%
William Demant Foundation’s donations: DKK 124.1 million

  • Revenue
  • 27%
  • 2021: DKK 18,418 million
  • 2020: DKK 14,469 million
  • Operating profit (EBIT)
  • 158%
  • 2021: DKK 3,386 million
  • 2020: DKK 1,313 million